VanEck Pharmaceutical ETF $PPH Shares Sold by Copia Wealth Management

Copia Wealth Management cut its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 11.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,429 shares of the company’s stock after selling 733 shares during the period. Copia Wealth Management owned about 0.10% of VanEck Pharmaceutical ETF worth $478,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Harbour Investments Inc. raised its stake in VanEck Pharmaceutical ETF by 9.7% in the second quarter. Harbour Investments Inc. now owns 4,450 shares of the company’s stock valued at $391,000 after buying an additional 394 shares in the last quarter. J.Safra Asset Management Corp raised its stake in VanEck Pharmaceutical ETF by 1.7% in the second quarter. J.Safra Asset Management Corp now owns 271,620 shares of the company’s stock valued at $23,759,000 after buying an additional 4,566 shares in the last quarter. Axxcess Wealth Management LLC raised its stake in VanEck Pharmaceutical ETF by 4.8% in the second quarter. Axxcess Wealth Management LLC now owns 9,114 shares of the company’s stock valued at $802,000 after buying an additional 416 shares in the last quarter. CWM LLC raised its stake in VanEck Pharmaceutical ETF by 167.9% in the second quarter. CWM LLC now owns 375 shares of the company’s stock valued at $33,000 after buying an additional 235 shares in the last quarter. Finally, Blair William & Co. IL raised its stake in VanEck Pharmaceutical ETF by 34.3% in the second quarter. Blair William & Co. IL now owns 12,295 shares of the company’s stock valued at $1,081,000 after buying an additional 3,140 shares in the last quarter.

VanEck Pharmaceutical ETF Price Performance

VanEck Pharmaceutical ETF stock opened at $91.85 on Wednesday. VanEck Pharmaceutical ETF has a 1-year low of $77.67 and a 1-year high of $95.27. The stock has a market cap of $1.23 billion, a PE ratio of 20.21 and a beta of 0.72. The stock’s fifty day moving average is $88.84 and its two-hundred day moving average is $87.51.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, October 6th. Shareholders of record on Wednesday, October 1st were paid a $0.3931 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $1.57 dividend on an annualized basis and a yield of 1.7%.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.